leisure time -WSS

leisure time

author：knowledge 2025-10-02 22:57:24 - browse：513

The Novartis booth at ESMO in Madrid. — The Novartis booth at ESMO 2023 in Madrid. Andrew Joseph/STAT

MADRID — Results presented Monday could expand the use of a Novartis therapy for metastatic prostate cancer, moving it from a treatment used after chemotherapy to one with demonstrated benefits beforehand as well.

The Phase 3 data, highlighted in a prime session here at the annual meeting of the European Society for Medical Oncology, also amount to another win for cancer therapies designed to deliver radiation directly to tumor cells. It’s a field that Novartis has poured investments into, and that is attracting interest from other pharma companies.

The trial, called PSMAfore, enrolled patients with a type of metastatic prostate cancer whose disease had started to progress after taking a drug known as an androgen receptor pathway inhibitor, or ARPI. Patients were randomized to either receive a different ARPI or Novartis’ therapy, Pluvicto.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Profiling embryos to choose those with higher IQs is almost a reality

WSS

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

Discs beat pads, tampons for heavy menstrual flow, new study shows

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

Allen Institute goes after foundational questions, CEO Costa says

FTX founder Sam Bankman

Travel bans should be based on evidence, not politics or fear

hotspot

leisure time

hotspot

Affirmative action in medical school literally saved lives

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

FDA approval of Sarepta Duchenne genetic therapy gives me hope

A preacher's new calling: Diversifying neuroscience research

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

STAT Virtual Event: JPM Recap, Live!

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Arena BioWorks launches in Cambridge to speed drug discovery

State Dept. review finds Biden bears some blame for Afghanistan failures

Life science postdocs should get big pay hike, NIH panel says

focus

Study suggests new cause of Down syndrome: cells linked to aging

FDA early review: GLP

Judge rejects Trump's counterclaim against E. Jean Carroll

Arena BioWorks launches in Cambridge to speed drug discovery

An Ebola outbreak presents a new mystery involving children

In venture capital firm's success, lessons for turning crisis into profit

leisure time

entertainment

knowledge

leisure time